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Abstract
Background: Toll-like receptors (TLRs) are critical components for host pathogen recognition and variants in genes
participating in this response influence susceptibility to infections. Recently, TLR1 gene polymorphisms have been found
correlated with whole blood hyper-inflammatory responses to pathogen-associated molecules and associated with sepsis-
associated multiorgan dysfunction and acute lung injury (ALI). We examined the association of common variants of TLR1
gene with sepsis-derived complications in an independent study and with serum levels for four inflammatory biomarkers
among septic patients.
Methodology/Principal Findings: Seven tagging single nucleotide polymorphisms of the TLR1 gene were genotyped in
samples from a prospective multicenter case-only study of patients with severe sepsis admitted into a network of intensive
care units followed for disease severity. Interleukin (IL)-1b, IL-6, IL-10, and C-reactive protein (CRP) serum levels were
measured at study entry, at 48 h and at 7th day. Alleles -7202G and 248Ser, and the 248Ser-602Ile haplotype were associated
with circulatory dysfunction among severe septic patients (0.001#p#0.022), and with reduced IL-10 (0.012#p#0.047) and
elevated CRP (0.011#p#0.036) serum levels during the first week of sepsis development. Additionally, the -7202GG
genotype was found to be associated with hospital mortality (p= 0.017) and ALI (p= 0.050) in a combined analysis with
European Americans, suggesting common risk effects among studies.
Conclusions/Significance: These results partially replicate and extend previous findings, supporting that variants of TLR1
gene are determinants of severe complications during sepsis.
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Introduction
Sepsis is a devastating clinical condition characterized by
systemic inflammation occurring in the setting of a severe
infection. Among intensive care unit (ICU) patients, incidence
and mortality has been estimated in ,12% and .40%,
respectively, for the most severe forms [1]. Over the past three
decades, a plethora of experimental and clinical studies have
contributed substantially to our understanding of sepsis develop-
ment and associated complications, including the acute lung injury
(ALI) and the acute respiratory distress syndrome (ARDS) [2].
Studies in animal models, and twin and association studies have
evidenced that the innate immune responses to pathogens show
inter-individual variability that is strongly influenced by genetic
factors, which may affect disease susceptibility and severity [3,4,5].
Toll-like receptor (TLR) pathways are critical components of
the immune response to pathogens [6], and targeting of TLRs
have been demonstrated to protect from lethal sepsis [7,8].
Polymorphisms in genes of the TLR-mediated responses are
associated with altered immunity [9,10,11], with susceptibility to
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infections and with related acute inflammatory syndromes,
including sepsis and severe complications such as ALI and ARDS
[12,13]. In an elegant study, Wurfel and colleagues screened
tagging single nucleotide polymorphisms (SNPs) across 49 TLR-
related genes for association with whole blood inflammatory
responses to pathogen-associated molecules in normal volunteers
[14]. This allowed the identification of various tightly linked SNPs
from the TLR1 gene associated with the strongest hyper-
inflammatory effects. In a subsequent association study in septic
patients focusing on two of the common TLR1 SNPs (-7202A/G
and Ser602Ile) revealed associations with organ dysfunction, 28-
day hospital mortality, ALI, and the prevalence of gram-positive
cultures, constituting the unique association study of TLR1 gene
variants with sepsis-associated complications to date.
Given the controversies around the association of genetic factors
with sepsis-associated outcomes because of the limited replicability of
findings [15,16], here we have examined the association of common
variants of TLR1 gene with sepsis outcomes in a cohort of patients
with severe sepsis admitted into a network of ICUs from Spain, in
order to provide an independent replication of previous results. We
additionally explored the relationship of TLR1 polymorphisms and of
particular haplotypes with serum levels of four biomarkers of
inflammation taken at three stages of sepsis development. We found
that TLR1 SNPs and haplotypes were associated with circulatory
dysfunction and the source of infection among severe septic patients,
and with hospital mortality and ALI in a combined analysis with data
from European Americans. Congruently, risk alleles associated with
increased nuclear factor kB (NF-kB) activation upon TLR1
stimulation in previous studies [17,18], were related with reduced
interleukin-10 and elevated C-reactive protein serum levels during
the first week of sepsis development.
Methods
Ethics Statement
This study was approved by the Ethics Committees of Hospital
Universitario N. S. de Candelaria and Hospital Universitario Rı´o
Hortega (Spain). Written informed consent was obtained from
each subject or appropriate surrogates.
Study Subjects
Samples were collected as part of a prospective, observational
study of adults admitted during 2003–2005 into a network of
Spanish ICUs. The study has been reported elsewhere [19] and
included consecutive patients admitted to ICUs older than 18
years old fulfilling the international criteria for severe sepsis
(n = 218) [20]. We collected basic demographic data, previous
health status, severity of illness scores and clinical information until
discharge from the ICU, including source of infection, pathogens,
and development of organ dysfunction. All patients were followed
prospectively for the development of ALI, as defined by the
American-European Consensus Conference [21] and for the
development of organ dysfunction included in the sequential organ
failure assessment (SOFA) scale [22]. For the purpose of this study,
patients with ALI and ARDS were analyzed as a single group of
ALI patients. Genomic DNA was isolated from peripheral whole
blood using commercial kits (GFX kit, GE Healthcare, Little
Chalfont, UK) and stored at 220uC until use. A summary
description of cases can be found in Table 1.
DNA samples from population-based controls (n = 346), ran-
domly drawn from a population-based study of about 7000
unrelated individuals as a representation of the general Spanish
population [23], were also genotyped but data were only used for
quality control purposes and not for association studies.
SNP selection and genotyping
Instead of focusing exclusively on the two previously associated
variants [14], we selected tagging SNPs (tSNPs) to efficiently study
common TLR1 gene variation in order to test whether additional
gene variants associated with the expression of the clinical
phenotype. TagIT 3.03 software [24] was used to select a set of
7 tSNPs from data available from 23 European-Americans
retrieved from the Innate Immunity NHLBI Program for
Genomic Applications (PGA) website (http://innateimmunity.
net/IIPGA2/index_html, accessed October 2008), forcing the
inclusion of previously associated tSNPs by Wurfel and colleagues
[14]. A SNP-dropping-with-re-sampling method [24] was used to
evaluate the expected properties of the TLR1 7 tSNPs set,
indicating an average haplotype r2.0.90.
Genotyping was conducted using the iPLEXTM Gold assay on
MassARRAY system (Sequenom, San Diego, CA) by the Spanish
National Genotyping Center, Santiago de Compostela Node
(CeGen, http://www.cegen.org). Briefly, iPLEXTM assays were
scanned by MALDI-TOF mass spectrometry and individual SNP
genotype calls were automatically generated using Sequenom
Table 1. Demographic and clinical features of patients with
severe sepsis.
Variable Cases (n = 218)
Gender, male (%) 59.2
Age, median years (P25–P75) 67 (54–75)
Previous health status (%)
Previous surgery 74.5
Hospitalized .24 h 78.8
Diabetes 16.1
Hypertension 46.0
Ischemic cardiac disease 9.3
Smoker 27.6
Source of infection (%)
Pulmonary 34.4
Extra-pulmonary 65.6
Identified pathogen (%)
Gram negative 23.9
Gram positive 15.1
Fungi 2.9
Mixed Gram negative and
positive
7.3
Polymicrobial 2.0
Negative blood cultures 48.8
Organ dysfunction (%)
Circulatory 83.1
Neurologic 22.1
Coagulation 22.1
Renal 33.8
Hepatic 15.5
APACHE II, median (P25–P75) 23 (18–27)
ALI or ARDS (%) 86.1
Hospital mortality (%) 52.7
Abbreviations: APACHE II, acute physiology and chronic health evaluation score
II; ALI, acute lung injury; ARDS, acute respiratory distress syndrome.
doi:10.1371/journal.pone.0013759.t001
TLR1 and Sepsis Outcomes
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TYPER 3.4TM software. Two tSNPs that failed in iPLEXTM Gold
assays (rs5743618 and rs5743551) were genotyped at Hospital
Universitario N. S. de Candelaria using TaqManTM assays
(Applied Biosystems, Foster City, CA) in a 7500 Fast Real-Time
PCR System (Applied Biosystems), with automated calls generated
using the 7500 software 2.0.1 based on discriminating plots with
95% confidence. Genotyping was blind to sample outcomes.
Approximately 10% of the samples were genotyped by duplicate
to monitor genotyping quality. Genotypes were assigned using all
data from the study simultaneously. Discrepancy rate among
duplicates was 0.51% (95% confidence interval [CI]: 0.17–1.49%)
for iPLEXTM Gold and 0.00% (95% CI: 0.00–2.11%) for
TaqManTM. Call rates and further quality-control measures for
genotyped tSNPs, as well as the correspondence of dbSNPs
reference numbers with SNP positions relative to the start codon,
can be found in Table 2.
Serum measurements
Serum was available only from a subset of 121 patients as dry-
ice transportation to the coordinating center was not warranted for
all participating centers. These samples were collected within
24 hours of meeting severe sepsis criteria, at 48 hours and 7 days
after study entry, only if the patient remained hospitalized into the
ICU. Given this, serum was available for all 121 patients at
inclusion, for 96 of these patients at 48 hours, and for 60 of these
patients at the 7th day. Serum was obtained by centrifuging
peripheral blood samples for 10 min at 3200 rpm within 35 min
after sampling and was kept at 280uC until measurements were
performed. These samples have been previously measured for four
commonly used biomarkers of acute inflammation, interleukin
(IL)-6, IL-1b, IL-10, and C-reactive protein (CRP) [25].
Measurements were done by duplicate using commercial kits:
IL-6, IL-1b, and IL-10 were assessed in an Immulite analyzer
(Siemens Medical Solutions Diagnostics, Caernarfon, UK), and
CRP was determined in a Hitachi 917 analyzer (Roche
Diagnostic, Basilea, Switzerland).
Statistical analysis
Departures from Hardy-Weinberg equilibrium (HWE) were
only tested in controls by means an efficient exact test [26].
Associations of SNPs with sepsis-derived complications were
assessed using logistic regression models by means of SNPassoc
[27] assuming additive effects for all SNPs. To replicate previous
association findings [14], recessive models were also applied for -
7202A/G and Ser602Ile SNPs as necessary. Logistic regressions
were also used to obtain SNP effects as odds ratios (ORs) with 95%
CI adjusting for age, gender, and the acute physiology and chronic
health evaluation score (APACHE) II. Genotype data available
from 20 unlinked polymorphisms from different parts of the
genome [13] were utilized to adjust individual SNP associations
for population stratification by means of a modified Cochran-
Armitage trend test [28]. A Mantel-Haenszel test over genotype
counts was used to perform the joint stratified analysis of the two
SNPs overlapping across our study and the previous one [14],
under the principle that if SNPs had consistent effects (i.e. allele
and effect-wise) among different studies, the joint analysis would
improve the results obtained from the two studies by separate.
Data were analyzed under recessive models with -7202GG and
602Ile/Ile genotypes as risk factors to emulate previous association
findings [14]. For this analysis, we did not consider non-septic
control sample genotype counts from Wurfel et al. [14], and used
data from the sepsis cohort to test associations with hospital
mortality and the CELEG cohort to test associations with ALI
development (Table S1). THESIAS [29] was used to assess the
association of particular TLR1 haplotypes with sepsis-derived
outcomes. A two-tailed p#0.05 was considered significant.
However, in order to estimate the chance that SNP associations
were true positives, we calculated the false-discovery rate (FDR)
overall comparisons using QVALUE [30]. The patterns of linkage
disequilibrium (LD), in terms of r2 values, were explored using
Haploview 3.32 [31].
Differences for serum biomarker levels between genotypes were
explored using general linear models (GLM) for repeated measures
in a longitudinal analysis over the three time points by means of
SPSS 15.0 (SPSS Inc., Chicago, IL). Although the four biomarkers
were measured for all 121 serum samples at inclusion, 96 serum
samples at 48 h and 60 serum samples at 7th day, the GLM
analysis tested for biomarker level differences between genotypes
over time. Thus, it only considered the 60 samples for which
measures were available for the three time points. Despite
dropping the sample size, GLM allowed to explore sustained
SNP relationships with biomarkers, under the rationale that these
were more likely to identify genuine associations. A post hoc analysis
of differences in biomarker levels between genotypes at individual
time points was also performed using all available serum measures
from each day by means of linear regression. These analyses were
performed under recessive models in order to emulate previous
functional findings in vitro [17,32,33]. Values for IL-6, IL-1b, and
IL-10 were logarithmically transformed for the analysis.
Results and Discussion
Among the 218 severe septic patients, the median APACHE II
score was 23 (interquartile range: 18–27), 55.0% percent
developed ARDS and 31.1% developed ALI during hospitaliza-
tion (Table 1). Peritonitis was the leading cause of severe sepsis
followed by pneumonia, and most pathogens were characterized
as Gram-negative bacteria. In agreement with previous studies
[34], no pathogens were identified in blood cultures as the
causative microorganism for sepsis albeit having an identified site
of infection for 48.8% of patients. Hospital mortality was 52.7%.
Table 2 shows that completion rates were .97% for all 7 tSNPs
and that all followed HWE expectations in control samples. None
of the tSNPs was significantly associated with hospital mortality or
with sepsis-induced ALI (Table 3). Borderline associations were
observed for the SNP Arg80Thr (rs5743611) with hospital
mortality (p=0.080), and for SNPs -7202A/G (rs5743551) and
Asn248Ser (rs4833095) with sepsis-induced ALI (p=0.100 and
p=0.090, respectively). The association of -7202A/G with hospital
mortality or with ALI did not improve if a recessive model was
Table 2. Quality control measures for the TLR1 tSNPs.
rs# tSNP position Location CR (%)
HWE p-value
in controls
rs5743551 -7202A/G 59 flanking 98.9 0.566
rs5743565 -5531A/G Intron 1 99.1 0.294
rs5743594 -2299C/T Intron 2 99.3 0.376
rs5743596 -2076C/T Exon 3 99.3 0.469
rs5743611 238C/G (Arg80Thr) Exon 4 98.8 1.000
rs4833095 742A/G (Asn248Ser) Exon 4 99.3 1.000
rs5743618 1804G/T (Ser602Ile) Exon 4 97.3 0.513
Abbreviations: CR, completion rate; HWE, Hardy-Weinberg equilibrium.
doi:10.1371/journal.pone.0013759.t002
TLR1 and Sepsis Outcomes
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used. However, analyses combining samples from this and the
previous study by Wurfel et al. [14], enabled the detection of a
weak risk of the -7202GG genotype for hospital mortality and for
ALI consistent across the two studies. The significance of the
association of -7202A/G with hospital mortality improved to
p=0.017 (p=0.028 in the previous study [14] and p=0.566 in this
study). Similarly, significance of the association of -7202A/G with
ALI among septic patients improved to p=0.050, while separate
findings were non-significant (p=0.171 in the previous study [14]
and p=0.108 in this study). For Ile602Ser (rs5743618), analyses
combining samples from this and the previous study by Wurfel
et al. [14], did not enable the detection of consistent significant
effects (results not shown). Contrary to previous findings [14],
none of the tSNPs showed a significant association with prevalence
of Gram-positive infections versus other types of pathogens, but
the SNPs -2299C/T (rs5743594) and -7202A/G showed border-
line associations (p=0.067 and p=0.110, respectively). Neverthe-
less, in our study, three tSNPs had nominal significance in
association with pulmonary infection among septic patients, which
is frequently caused by Gram-positive bacteria [1,35]: -5531A/G
(rs5743565) with p=0.004, -2076C/T (rs5743596) with p=0.004,
and Asn248Ser with p=0.037. However, when adjusted for
covariates using regression models, results remained significant for
-5531A/G (OR for -5531A: 1.84, 95% CI: 1.10–3.10, p=0.023)
and for -2076C/T (OR for -2076C: 1.90, 95% CI: 1.07–3.39,
p=0.029), but not for Asn248Ser (OR for 248Ser: 1.44, 95% CI:
0.92–2.26, p=0.112). Similar findings were obtained after
applying a conservative correction for population stratification,
as only the association of -5531A/G with pulmonary infec-
tion remained significant (p=0.047, p=0.057 and p=0.127
for -5531A/G, -2076C/T and Asn248Ser, respectively).
The strongest associations of TLR1 tSNPs with sepsis-derived
complications were found with circulatory dysfunction (Table 3).
Three tSNPs, -7202A/G, Asn248Ser, and Ser602Ile, showed p-
values ranging from 0.001 to 0.024. The association of -7202A/G
remained significant after adjusting for covariates (OR for -7202G:
2.68, 95% CI: 1.40–5.12, p=0.003) and population stratification
(p=0.031). The associations for Asn248Ser and Ser602Ile also
persisted when adjusting for covariates (OR for 248Ser: 2.13, 95%
CI: 1.16–3.90, p=0.015; OR for 602Ile: 1.94, 95% CI: 1.10–3.44,
p=0.023) and showed borderline significance after the conserva-
tive adjustment for population stratification (p=0.061 for
Asn248Ser and p=0.064 for Ser602Ile). In the context of the
multiple tests performed, some of the above findings might
represent true positives. In particular, FDR was below 5% for the
association of -7202G/A with circulatory dysfunction, which
partially replicates the study by Wurfel et al. [14], which reported
the association of this TLR1 SNP with circulatory, neurologic,
coagulation, renal and hepatic dysfunction among septic patients.
However, one must take into account the power limitation of this
association study. Assuming a minor allele frequency of 30% (as is
the case for -7202A/G) and an OR of 2.0, in the range of values
reported by Wurfel et al [14], statistical power ranged from 39%
to 69% for the outcomes tested, which might be responsible for the
lack of replication in the association of TLR1 variants with some of
the outcomes.
Many evidences point to the SNP Ser602Ile as the main
responsible for the inter-individual variation in TLR1-mediated
responses, 602Ser allele being related to a decrease in NF-kB
activity [14,17,18,32]. Albeit the SNP Asn248Ser have demon-
strated no functional relevance [14,18], previous association
studies have indicated that it might be important for disease
susceptibility [14,36,37,38]. Thus, we were interested in testing the
association of the ancestral haplotype 248Ser-602Ile [18] with
sepsis-derived complications, motivated by the observation that
this haplotype consistently tends to associate with the highest NF-
kB activation upon TLR1 stimulation in independent studies [17].
In particular, we were interested in evaluating whether haplotypes
of these two SNPs were more strongly associated with circulatory
dysfunction than the two SNPs by separate. However, our results
showed that, although 248Ser-602Ile haplotype homozygous
subjects were more frequent among patients with circulatory
dysfunction (17.5%) than in the rest of patients (5.6%), being a risk
factor for circulatory dysfunction (OR: 2.07, 95% CI: 1.12–3.82,
p=0.020), statistical significance did not improve considerably
compared to those obtained for Asn248Ser and Ser602Ile
individually.
A number of studies have explored the functional effects of
TLR1 variants in vitro [14,17,32]. However, no study have explored
if TLR1 variants are associated with amplified immune responses
to pathogens in vivo. Given that serial serum measures for four
biomarkers of inflammation were available from these patients
during the first week after the onset of severe sepsis (Table S2), we
correlated tSNPs genotypes with biomarker serial measures using
GLM (Table 4). None of the tSNPs was found to be associated
with serially-measured IL-1b and IL-6 serum levels, despite
previous studies have demonstrated that TLR1 gene polymor-
phisms determined IL-6 levels in response to specific gram-
Table 3. Association p-values of TLR1 tSNPs with severe sepsis complications.
Organ dysfunction
tSNP
Hospital
mortality
Acute lung
injury
Gram positive
infection
Pulmonary
infection Circulatory Neurologic Coagulation Renal Hepatic
-7202A/G 0.306
(0.566)
0.100
(0.108)
0.253
(0.110)
0.129
(0.399)
0.001
(0.008)
0.621
(0.618)
0.464
(0.618)
0.641
(0.382)
0.657
(0.982)
-5531A/G 0.648 0.182 0.714 0.004 0.501 0.224 0.224 0.156 0.574
-2299C/T 0.818 0.845 0.067 0.803 0.111 0.935 0.935 0.428 0.737
-2076C/T 0.327 0.405 0.738 0.004 0.551 0.372 0.372 0.273 0.941
238C/G (Arg80Thr) 0.080 0.181 0.622 0.151 1.000 1.000 0.861 0.642 0.363
742A/G (Asn248Ser) 0.530 0.090 0.438 0.037 0.009 0.481 0.481 0.986 0.671
1804G/T (Ser602Ile) 0.164 (0.208) 0.142 (0.343) 0.129 0.309 (0.677) 0.024 0.557 0.310 0.988 0.463
In parenthesis, p-value for a recessive model; nominal significances in bold.
doi:10.1371/journal.pone.0013759.t003
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negative bacterial products [14]. On the other hand, CRP and IL-
10 levels varied significantly among genotypes for four of the TLR1
variants, with p-values ranging from 0.002 to 0.047. However,
given the assessment used in this study to explore TLR1 SNP
relationships with biomarkers, statistical power was limited for
most comparisons, particularly for those involving IL-6 and IL-1b
Table 4. P-values and statistical power (%) from the longitudinal analysis of differences in serum biomarker levels by TLR1 tSNPs.
tSNP IL-1b IL-6 CRP IL-10
p-value Power p-value Power p-value Power p-value Power
-7202A/G 0.714 6.5 0.277 19.0 0.036 56.1 0.012 72.2
-5531A/G 0.614 7.9 0.433 12.1 0.995 5.0 0.009 76.3
-2299C/T 0.527 9.6 0.408 13.0 0.288 18.4 0.413 12.8
-2076C/T 0.916 5.1 0.148 30.2 0.002 88.8 0.076 42.7
238C/G (Arg80Thr) 0.380 14.0 0.186 26.1 0.476 10.9 0.640 7.5
742A/G (Asn248Ser) 0.902 5.2 0.307 17.3 0.011 73.5 0.047 51.6
1804G/T (Ser602Ile) 0.685 6.9 0.320 16.7 0.129 32.8 0.117 34.7
Nominal significances in bold.
doi:10.1371/journal.pone.0013759.t004
Figure 1. IL-6, IL-1b, IL-10, and CRP serum levels according to the TLR1 248Ser-602Ile haplotype status. Values represent mean 6 SEM
biomarker levels at inclusion, at 48 hours, and at 7th day for patients showing homozygosity for the TLR1 248Ser-602Ile haplotype (n = 8) and for the
rest of patients (n = 52). Note that values represented correspond to those from the 60 severe septic patients with serum measures available at the
three time points. Significance of biomarker differences by the haplotype status was obtained using general linear models (GLM) for repeated
measures in a longitudinal analysis assuming a recessive model (CRP, p= 0.024; IL-10, p=0.015; for IL-1b and IL-6, p$0.45).
doi:10.1371/journal.pone.0013759.g001
TLR1 and Sepsis Outcomes
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for which it was below 30% (Table 4). Nevertheless, congruent
with our previous results, homozygote patients for -7202G or
248Ser alleles, both constituting risk alleles for sepsis-associated
complications, showed significantly increased levels for CRP
(p=0.036 and p=0.012, respectively) and lower levels for the
compensatory anti-inflammatory cytokine IL-10 (p=0.011 and
p=0.047, respectively) (Table 4), regardless of the in vitro findings
suggesting higher IL-10 levels for the -7202GG genotype in
response to TLR1/TLR2 agonists [14]. This sustained pro-
inflammatory state was also observed for patients homozygous for
the risk haplotype 248Ser-602Ile (n = 8), associated with the
highest NF-kB activation upon TLR1 stimulation [17], compared
to the rest of patients (n = 52; p=0.024 and p=0.015 for CRP and
IL-10 serial measures, respectively; p$0.45 for IL-1b and IL-6)
(Figure 1), slightly improving significance levels over individual
SNP comparisons. Results for the longitudinal analysis barely
changed when tests were performed under additive models or
when adjusted for age, gender, and APACHE II (not shown).
It is worth noting that no demographical or clinical differences
were found between samples considered in the GLM analysis of
TLR1 SNP genotypes and serial measures of biomarkers, i.e. those
patients who were not discharged from the ICU or were not dead
before seven days, and patients without serum measures at the three
time points, except for mortality (p=0.033). Thus, it is reasonable to
assume that this GLM biomarker analysis might be biased towards
the expected for survivor patients. We explored such possibility by a
post hoc analysis of differences in biomarker levels at individual time
points among genotypes using all available serum measures. This
analysis supported the strong correlation of TLR1 SNPs with CRP
and IL-10 levels observed before, while revealed barely significant
relationships of TLR1 SNPs with IL-6 and IL-1b levels (Table S3),
indicating that GLM results were not as biased as predicted.
Due to the remarkable effects on NF-kB activation, Ser602Ile
has been put forward as the principal functional variant affecting
TLR1 activity across the whole chromosome region encompassing
TLR10-TLR1-TLR6 genes [18]. Nevertheless, we found stronger
associations for SNPs -7202G/A and Asn248Ser with sepsis
complications and with biomarker serum levels, in agreement with
previous association studies [14,36], albeit no functional properties
have been described for them individually [14]. The LD between -
7202G/A and Asn248Ser was strong (r2 = 0.84), while the LD of
these two with Ser602Ile was moderate in our sample (Figure 2), as
has been found elsewhere [18,39]. Furthermore, Asn248Ser have
been associated with Leprosy and Malaria in populations where
Ile602Ser is rare or absent [37,38], indicating that it (or other
variant in LD with it) might be relevant for susceptibility to
infections. Given this, and the fact that associations found for
Ser602Ile were weak unless considered into haplotypes, the
evidences suggest that a more complex scenario, possibly involving
other rare and common functional variants, underlie TLR1 gene
effect on the phenotype. Alternatively, unexplored epistatic
interactions with other gene variants relevant for the TLR-
mediated responses (e.g. TLR4 Asp299Gly, TIRAP/Mal Ser180-
Leu, etc) might be needed to be able to detect Ser602Ile effects on
this devastating clinical condition.
In conclusion, despite the limited power of the study, here we
have replicated the association of TLR1 gene variants, with
established increased NF-kB activation in vitro, with risk for
circulatory dysfunction during severe sepsis, and associated TLR1
variants with elevated CRP and decreased IL-10 levels in serum
during the first week of sepsis development. In line with previous
evidences, our results suggest that genetic factors favouring an
exacerbated host pro-inflammatory response to an infection
predisposes to sepsis complications.
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